HGH Frag 176-191

Description

HGH Fragment 176-191 is a stabilized analogue of the factor-releasing factor generic growth hormone. It represents the C-terminal tail of the Human Growth Hormone (hGH) molecule, specifically isolating amino acids 176 through 191. Researchers have identified this specific fragment as the region primarily responsible for the lipid-mobilizing (fat-burning) properties of the full growth hormone molecule.

Unlike the intact 191-amino acid Growth Hormone, HGH Frag 176-191 does not bind to the hGH receptor in a way that stimulates Insulin-Like Growth Factor 1 (IGF-1) secretion. This unique characteristic allows for targeted research into adipose tissue reduction without the variables of glycemic volatility or cell proliferation associated with full hGH.

Key Research Applications

• Lipolysis & Metabolism: Investigated heavily for its ability to stimulate the breakdown of adipose tissue (lipolysis) and inhibit the deposition of new fat (lipogenesis).

• Glycemic Control: Studies suggest this fragment does not induce hyperglycemia or insulin resistance, distinguishing it from unmodified hGH.

• Bone & Cartilage: Preliminary research indicates potential applications in the regeneration of cartilage and bone mineral density.

⚠️ FOR RESEARCH PURPOSES ONLY This product is intended for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic use. Handle with care and adhere to all laboratory safety protocols.